tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), DENTSPLY SIRONA (XRAY) and Viatris (VTRS)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGNResearch Report), DENTSPLY SIRONA (XRAYResearch Report) and Viatris (VTRSResearch Report).

Amgen (AMGN)

In a report issued on March 1, Brian Skorney from Robert W. Baird maintained a Sell rating on Amgen, with a price target of $185.00. The company’s shares closed last Wednesday at $228.59.

According to TipRanks.com, Skorney is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -7.0% and a 41.4% success rate. Skorney covers the Healthcare sector, focusing on stocks such as Eiger Biopharmaceuticals, Vertex Pharmaceuticals, and Enanta Pharmaceuticals.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Amgen with a $244.00 average price target.

See today’s best-performing stocks on TipRanks >>

DENTSPLY SIRONA (XRAY)

In a report issued on February 28, Jeff Johnson from Robert W. Baird reiterated a Buy rating on DENTSPLY SIRONA, with a price target of $67.00. The company’s shares closed last Wednesday at $52.48.

According to TipRanks.com, Johnson is a 5-star analyst with an average return of 25.3% and a 64.2% success rate. Johnson covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Tandem Diabetes Care, and Envista Holdings.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for DENTSPLY SIRONA with a $63.70 average price target, a 17.5% upside from current levels. In a report issued on February 28, Evercore ISI also maintained a Buy rating on the stock with a $65.00 price target.

Viatris (VTRS)

In a report released yesterday, Lorenzo Biasio from Credit Suisse downgraded Viatris to Hold, with a price target of $14.50. The company’s shares closed last Wednesday at $10.48, close to its 52-week low of $9.68.

According to TipRanks.com, Biasio is a 4-star analyst with an average return of 7.3% and a 60.5% success rate. Biasio covers the Healthcare sector, focusing on stocks such as Intuitive Surgical, Merck & Company, and Thermo Fisher.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Viatris with a $16.88 average price target, which is a 66.5% upside from current levels. In a report issued on March 1, Bank of America Securities also downgraded the stock to Hold with a $13.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on AMGN:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos
---

Latest News Feed